Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
| ▸ | CCR2 | P41597 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7702219 | 0.98 | GAA (0.69) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL16064910 | 0.96 | EPHX1 (0.63) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL12218333 | 0.94 | GAA (0.65) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL28826584 | 0.92 | EPHX1 (0.67) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL14503263 | 0.87 | GAA (0.79) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL3183223 | 0.85 | EPHX2 (0.60) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL3183232 | 0.85 | EPHX2 (0.60) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL5144107 | 0.83 | EPHX1 (0.61) | GAAEPHX1EPHX2CCR2KMT2A | |
| SCHEMBL1548101 | 0.80 | EPHX1 (0.72) | GAAEPHX1EPHX2KMT2ASMN1; SMN2 | |
| SCHEMBL19526412 | 0.79 | EPHX1 (0.51) | GAAEPHX1EPHX2KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9883997-B2 | Cosmetic compositions with tricyclodecane amides | CONOPCO, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| EP-2969026-B1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2017-11-01 | — | — | EP | disclosed |
| US-9775793-B2 | Prolonged delivery of certain fragrance components from personal care compositions | CONOPCO, INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-9682028-B2 | Personal care photoprotective compositions with tricyclodecane amides | CONOPCO, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| EP-2968082-B1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2017-02-01 | — | — | EP | disclosed |
| US-20160045419-A1 | PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-02-18 | — | — | US | disclosed |
| US-20160015616-A1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-21 | — | — | US | disclosed |
| US-20160008249-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2014139965-A1 | PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014139952-A2 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014139963-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160015616-A1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | DPM1, DHCR24, POLR1C | GAA 652/4885EPHX1 4491/4885EPHX2 2910/4885 |
| US-20160045419-A1 | PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | CUTA, ERCC1, ERCC5 | GAA 3273/4885EPHX1 3243/4885EPHX2 2446/4885 |
| US-20160008249-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | CUTA, ACMSD, LAGE3 | GAA 1556/4885EPHX1 1888/4885EPHX2 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.